EchoGo Heart Failure
510(k) K222463
EchoGo Heart Failure is a medical device (FDA Class II; FDA product code QUO, Adjunctive Heart Failure Status Indicator) made by Ultromics Limited, cleared under FDA 510(k) K222463 on 23 Nov 2022, active as of 11 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK222463 | Date23 Nov 2022 | StatusActive |
Official records
- FDA 510(k) database K222463
From the FDA record
- Received by the FDA
- 15 Aug 2022
- FDA decision
- 23 Nov 2022 (Substantially Equivalent)
- FDA review time
- 100 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QUO
- Device class
- Class II
- Regulation
- 21 CFR Part 870.2200
- Advisory committee
- Cardiovascular
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K222463
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| EchoGo Heart Failure 1.0 | Heart Failure 1.0 | 05060634690041 | — | On the market |
Similar devices
Other devices filed under FDA product code QUO (Adjunctive Heart Failure Status Indicator).